Table 3.
Treatment | Storage time (days) | ||||
---|---|---|---|---|---|
0 | 7 | 14 | 21 | 28 | |
(A) Weight loss (%) | |||||
Control | 0.00f | 4.59a-f | 9.06a-c | 9.33ab | 11.14a |
10.0 % GA | 0.00f | 1.92d-f | 3.55b-f | 6.84a-e | 9.08a-c |
1.5 % GE | 0.00f | 2.05d-f | 4.36b-f | 6.25a-f | 7.02a-e |
2.0 % GO | 0.00f | 2.91b-f | 3.82b-f | 6.05a-f | 8.01a-d |
1.5%GE + 10.0%GA | 0.00f | 1.71d-f | 2.51c-f | 4.14b-f | 5.60a-f |
2.0%GO + 10.0%GA | 0.00f | 1.21ef | 2.14d-f | 4.11b-f | 5.38a-f |
(B) Firmness (N) | |||||
Control | 104.63a | 17.53d | 17.75d | 16.71d | 20.04d |
10.0 % GA | 104.63a | 51.78a-d | 28.17 cd | 24.22 cd | 26.58 cd |
1.5 % GE | 104.63a | 63.36 a-d | 51.08a-d | 39.96b-d | 42.75b-d |
2.0 % GO | 104.63a | 53.84a-d | 48.78a-d | 43.32b-d | 22.53d |
1.5%GE + 10.0%GA | 104.63a | 88.61ab | 55.98a-d | 43.16b-d | 25.71 cd |
2.0%GO + 10.0%GA | 104.63a | 102.72a | 79.04a-c | 43.34b-d | 21.83d |
(C) Soluble solid concentration (%) | |||||
Control | 6.50b | 10.38ab | 10.67a | 10.29ab | 8.96ab |
10.0 % GA | 6.50b | 8.67ab | 10.79a | 10.21ab | 7.96ab |
1.5 % GE | 6.50b | 9.92ab | 10.42ab | 8.46ab | 6.88ab |
2.0 % GO | 6.50b | 9.58ab | 9.83ab | 8.67ab | 9.29ab |
1.5%GE + 10.0%GA | 6.50b | 6.67ab | 9.00ab | 9.33ab | 9.08ab |
2.0%GO + 10.0%GA | 6.50b | 7.46ab | 8.21ab | 7.04ab | 10.08ab |
(D) Titratable acidity (%) | |||||
Control | 0.050a | 0.034a-c | 0.033a-c | 0.042a-c | 0.040a-c |
10.0 % GA | 0.050a | 0.032bc | 0.035a-c | 0.029c | 0.045a-c |
1.5 % GE | 0.050a | 0.041a-c | 0.037a-c | 0.040a-c | 0.031bc |
2.0 % GO | 0.050a | 0.043a-c | 0.041a-c | 0.042a-c | 0.041a-c |
1.5%GE + 10.0%GA | 0.050a | 0.040a-c | 0.050a | 0.042a-c | 0.037a-c |
2.0%GO + 10.0%GA | 0.050a | 0.050a | 0.044a-c | 0.04ab | 0.043a-c |